Patents by Inventor David Kilpatrick

David Kilpatrick has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Typing of human enteroviruses
    Publication number: 20050123908
    Abstract: The present invention discloses a method for detecting the presence of an enterovirus in a clinical sample. The invention additionally discloses a method for typing an enterovirus in a clinical sample. Both methods employ a set of primer oligonucleotides for reverse transcription and amplification that hybridize to conserved regions of the enterovirus genome, and that provide amplicons that include significant portions of the VP1 region that are characteristic of the various serotypes. In the typing method, the invention further provides a database consisting of nucleotide sequences from prototypical enteroviral serotypes, which is used to type the clinical sample by comparing the sequence of its amplicon with each prototypical sequence in the database.
    Type: Application
    Filed: January 25, 2005
    Publication date: June 9, 2005
    Inventors: Steven Oberste, Kaija Maher, David Kilpatrick, Mark Pallansch
  • Detection and identification of non-polio enteroviruses
    Patent number: 6168917
    Abstract: This invention provides sensitive nucleic acid hybridization assay methods for the detection of non-polio enterovirus nucleic acids. The methods are particularly useful in detecting the presence of enterovirus nucleic acids in a biological sample and for ascertaining the serotype of enteroviruses present in a sample.
    Type: Grant
    Filed: July 9, 1999
    Date of Patent: January 2, 2001
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventor: David Kilpatrick